ELSE NUTRITION PROVIDES BI-WEEKLY DEFAULT STATUS REPORT
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has provided a bi-weekly default status report following a Management Cease Trade Order (MCTO) granted by the British Columbia Securities Commission. The MCTO was issued due to delays in completing audit procedures for the company's 2024 annual financial statements. The order restricts trading by the CEO and CFO but does not affect other shareholders.
The company confirms no material changes since the initial MCTO announcement on April 1, 2025, and is working with auditors to complete the financial statements. Else Nutrition expects to file its Annual Filings, including MD&A and AIF, by May 27, 2025, with a final deadline of May 30, 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) ha fornito un rapporto bisettimanale sullo stato di default a seguito di un Ordine di Sospensione del Commercio per la Direzione (MCTO) emesso dalla British Columbia Securities Commission. L'MCTO è stato rilasciato a causa di ritardi nel completamento delle procedure di revisione per i bilanci annuali 2024 dell'azienda. L'ordine limita la negoziazione da parte del CEO e del CFO, ma non coinvolge gli altri azionisti.
L'azienda conferma che non ci sono state modifiche sostanziali dalla comunicazione iniziale dell'MCTO del 1° aprile 2025 e sta collaborando con i revisori per completare i bilanci. Else Nutrition prevede di presentare i suoi documenti annuali, inclusi MD&A e AIF, entro il 27 maggio 2025, con una scadenza finale fissata al 30 maggio 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) ha proporcionado un informe quincenal sobre el estado de incumplimiento tras una Orden de Suspensión Comercial para la Dirección (MCTO) otorgada por la Comisión de Valores de Columbia Británica. La MCTO se emitió debido a retrasos en la finalización de los procedimientos de auditoría para los estados financieros anuales 2024 de la compañía. La orden restringe las operaciones del CEO y CFO, pero no afecta a otros accionistas.
La compañía confirma que no ha habido cambios materiales desde el anuncio inicial de la MCTO el 1 de abril de 2025 y está trabajando con los auditores para completar los estados financieros. Else Nutrition espera presentar sus informes anuales, incluyendo MD&A y AIF, antes del 27 de mayo de 2025, con una fecha límite final el 30 de mayo de 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF)는 브리티시컬럼비아 증권위원회가 발행한 경영진 거래중지명령(MCTO)에 따른 격주 기본 상태 보고서를 제공했습니다. MCTO는 회사의 2024년 연간 재무제표 감사 절차 완료 지연으로 인해 발행되었습니다. 이 명령은 CEO와 CFO의 거래를 제한하지만 다른 주주에게는 영향을 미치지 않습니다.
회사는 2025년 4월 1일 최초 MCTO 발표 이후 중대한 변경 사항이 없음을 확인했으며, 감사인과 협력하여 재무제표를 완료하고 있습니다. Else Nutrition은 2025년 5월 27일까지 MD&A 및 AIF를 포함한 연례 보고서를 제출할 예정이며, 최종 마감일은 2025년 5월 30일입니다.
Else Nutrition Holdings (TSX : BABY) (OTCQX : BABYF) a fourni un rapport bimensuel sur l’état de défaut suite à une Ordonnance d’Interdiction de Négociation pour la Direction (MCTO) délivrée par la Commission des Valeurs Mobilières de la Colombie-Britannique. La MCTO a été émise en raison de retards dans l’achèvement des procédures d’audit pour les états financiers annuels 2024 de la société. L’ordonnance restreint les transactions du PDG et du CFO, mais n’affecte pas les autres actionnaires.
La société confirme qu’il n’y a eu aucun changement important depuis l’annonce initiale de la MCTO le 1er avril 2025 et travaille avec les auditeurs pour finaliser les états financiers. Else Nutrition prévoit de déposer ses documents annuels, y compris le MD&A et l’AIF, d’ici le 27 mai 2025, avec une date limite finale au 30 mai 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) hat einen zweiwöchentlichen Statusbericht zum Zahlungsverzug nach einem von der British Columbia Securities Commission erteilten Management Cease Trade Order (MCTO) veröffentlicht. Die MCTO wurde aufgrund von Verzögerungen bei der Durchführung der Prüfungsverfahren für die Jahresabschlüsse 2024 des Unternehmens erlassen. Die Anordnung beschränkt den Handel durch den CEO und CFO, betrifft jedoch keine anderen Aktionäre.
Das Unternehmen bestätigt, dass es seit der ersten MCTO-Ankündigung am 1. April 2025 keine wesentlichen Änderungen gab und arbeitet mit den Prüfern zusammen, um die Abschlüsse fertigzustellen. Else Nutrition plant, seine Jahresunterlagen einschließlich MD&A und AIF bis zum 27. Mai 2025 einzureichen, mit einer endgültigen Frist am 30. Mai 2025.
- None.
- Delay in filing 2024 annual financial statements, MD&A, and AIF beyond the required 90-day period
- Management Cease Trade Order (MCTO) restricting CEO and CFO from trading company securities
On April 1, 2025, the Company announced in a news release (the "MCTO Announcement") that it has been granted a voluntary cease trade order ("MCTO") by British Columbia Securities Commission in accordance with National Policy 12-203 due to time constraints in completing the audit procedures for the filing of its annual financial statements, management's discussion and analysis ("MD&A") and annual information form ("AIF")(collectively, the "Annual Filings") for the year ended December 31, 2024 on SEDAR within 90 days of its financial year-end. The MCTO prohibits the Chief Executive Officer and Chief Financial Officer from all trading in securities of the Company until such time as the Annual Filings have been filed by the Company and the MCTO has been lifted. The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.
Pursuant to NP 12-203, the Company must file bi-weekly default status reports in the form of further news releases during the period of the MCTO. The Company confirms that since the date of the MCTO Announcement: (i) there has been no material change to the information contained as set out in the MCTO Announcement; (ii) there has been no failure to satisfy the provisions of the alternative information guidelines set out in NP 12-203; (iii) there has not been any other specified default subsequent by the Company under NP 12-203; and (iv) there is no other material information concerning the affairs of the Company that has not been generally disclosed.
The Company reports that it is working diligently with its auditor to complete the audit of the financial statements for the year ended December 31, 2024. The company expects to file its Annual Filings by May 27, and in any event no later than May 30, 2025, and will issue a news release once they have been filed. Until filing of the Annual Filings, the Company intends to satisfy the provisions of the alternative information guidelines as required by NP 12-203.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at
Milan 's Global Food Innovation Summit - #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
- During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include but are not limited to, statements with respect to the Company filing its annual financial statements, MD&A and AIF. These forward-looking statements are made as of the date of this press release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, variations in market conditions; currency exchange rates; the Company's ability to obtain any necessary permits, consents or authorizations required for its activities; the Company's ability to access further funding, to continue its projected growth, or to be fully able to implement its business strategies. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-provides-bi-weekly-default-status-report-302454631.html
SOURCE Else Nutrition Holdings Inc.
FAQ
Why did Else Nutrition (BABYF) receive a Management Cease Trade Order in May 2025?
When will Else Nutrition (BABYF) file its 2024 annual financial statements?
Does the MCTO affect all BABYF shareholders' ability to trade?
What reports are delayed in Else Nutrition's 2024 annual filings?
